Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iopamidol dose finding in MDCTA for coronary artery stenosis
NCT00558792Phase 2Completed
- Sponsor
- Bracco Diagnostics Inc.
- Start
- Nov 2007
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of iopamidol in coronary artery disease (CAD), sponsored by Bracco Diagnostics Inc.. Started Nov 2007; status: completed.
02
Drugs
iopamidol
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00558792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00558792.